Esophageal cancer proliferation is mediated by cytochrome P450 2C9 (CYP2C9)-Reference-Cited by-同舟云学术

Esophageal cancer proliferation is mediated by cytochrome P450 2C9 (CYP2C9)

Published:2011-02 Issue:1-2 Volume:94 Page:25-33
ISSN:1098-8823
Container-title:Prostaglandins & Other Lipid Mediators
language:en
Short-container-title:Prostaglandins & Other Lipid Mediators

Author:

Schmelzle Moritz,Dizdar Levent,Matthaei Hanno,Baldus Stephan E.,Wolters Judith,Lindenlauf Nina,Bruns Ingmar,Cadeddu Ron-Patrick,Kröpil Feride,Topp Stefan A.,Schulte am Esch Jan,Eisenberger Claus F.,Knoefel Wolfram T.,Stoecklein Nikolas H.

Publisher

Elsevier BV

Subject

Cell Biology,Pharmacology,Physiology,Biochemistry

Reference30 articles.

1. Human cytochrome p450 enzymes of importance for the bioactivation of methyleugenol to the proximate carcinogen 1′-hydroxymethyleugenol;Jeurissen;Chem Res Toxicol,2006

2. Phase I/II enzyme gene polymorphisms and esophageal cancer risk: a meta-analysis of the literature;Yang;World J Gastroenterol,2005

3. Human cytochrome P450 CYP2A13: predominant expression in the respiratory tract and its high efficiency metabolic activation of a tobacco-specific carcinogen, 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone;Su;Cancer Res,2000

4. Lung cancer risk in relation to the CYP2C9 genetic polymorphism among Caucasians in Los Angeles County;London;Pharmacogenetics,1997

5. Epoxide hydrolase and CYP2C9 polymorphisms, cigarette smoking, and risk of colorectal carcinoma in the Nurses’ Health Study and the Physicians’ Health Study;Tranah;Mol Carcinog,2005

Cited by 26 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. GPD1L may inhibit the development of esophageal squamous cell carcinoma through the PI3K/AKT signaling pathway： bioinformatics analysis and experimental exploration;2024-08-30

2. Integrative Analysis of Histone Acetylation Regulated CYP4F12 in Esophageal Cancer Development;Drug Metabolism and Disposition;2024-05-29

3. Evaluating the Association of Genetic Polymorphism of Cytochrome p450 (CYP2C9*3) in Gastric Cancer Using Polymerase Chain Reaction-Restriction Fragment Length Polymorphism (PCR-RFLP);Cureus;2022-07-25

4. Study on the levels of N-nitrosamine compounds and untargeted metabolomics in patients with colorectal cancer;Analytical and Bioanalytical Chemistry;2022-02-16

5. Cytochrome P450-derived fatty acid epoxides and diols in angiogenesis and stem cell biology;Pharmacology & Therapeutics;2021-11